LifeMD to Report Second Quarter 2024 Financial Results on August 7

NEW YORK, July 30, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on August 7, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.

Conference Call & Webcast Details

Date: Wednesday, August 7th
Time: 4:30 p.m. Eastern time
Toll-Free Dial-In: 1-800-245-3047
International Dial-In: 1-203-518-9765
Conference ID: LIFEMD
Live & Archived Webcast: Link
   

About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com

Staff

Recent Posts

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…

5 hours ago

Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care

MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…

5 hours ago

LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026

Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…

5 hours ago

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

5 hours ago

Through High-Profile Ambassadors and Major Partnerships, ZetrOZ Systems Expanded Reach of sam Device in 2025

The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…

8 hours ago